NCT05776108
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
Clinical trial condition
Sexually Transmitted Diseases
Explore clinical trials studying Sexually Transmitted Diseases. Study availability and eligibility vary by location and protocol.
6,120 public trials
374 recruiting studies
Sexually Transmitted Diseases trial results
NCT00643903
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT01886404
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT03510091
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
- Locations
-
- LeBonheur Children's Hospital General Pediatrics Clinic Memphis, Tennessee, United States
NCT05074251
- Conditions
- ART, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- Department of Health Clinics Nkangala, Mpumalanga, South Africa
NCT03994835
- Conditions
- Blood-Borne Infections, Cardiovascular Diseases, Communicable Diseases, +19 more
- Locations
-
- Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands
- Radboudumc Nijmegen, Netherlands
- Erasmus MC Rotterdam, Netherlands
- Elisabeth Twee-Steden ziekenhuis Tilburg, Netherlands
NCT02831764
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Sacramento, California, United States
- GSK Investigational Site San Francisco, California, United States
NCT04563845
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
Completed
Relative Bioavailability Study to Investigate a Potential Interaction Between DTG DT and F/TAF TOS.
NCT05489406
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- RTCCS Radboudumc Nijmegen, Netherlands
NCT00144248
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +14 more
- Locations
-
- Boehringer Ingelheim Investigational Site Bakersfield, California, United States
- Boehringer Ingelheim Investigational Site San Francisco, California, United States
- California Pacific Medical Center San Francisco, California, United States
- Albany Medical College, MC 142 Albany, New York, United States